Solid Neoplasm

Oncology

53 drugs in development·14 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(10)

Drug	Company
Alpelisib	Relay Therapeutics, Inc. (RLAY)
EGFR-TKI inhibitor based on investigator's choice	Relay Therapeutics, Inc. (RLAY)
Erlotinib Hydrochloride	Amneal Pharmaceuticals, Inc. (AMRX)
Neratinib Maleate	ENANTA PHARMACEUTICALS INC (ENTA)
Neratinib Maleate	Relay Therapeutics, Inc. (RLAY)
Neratinib Maleate	Merus N.V. (MRUS)
Niraparib	Merus N.V. (MRUS)
Olaparib	Merck & Co., Inc. (MRK)
Panitumumab	ENANTA PHARMACEUTICALS INC (ENTA)
platinum	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Phase 2(28)

Drug	Company
Alpelisib	ADMA BIOLOGICS, INC. (ADMA)
Alpelisib	ENANTA PHARMACEUTICALS INC (ENTA)
Alpelisib	Merus N.V. (MRUS)
Binimetinib	Relay Therapeutics, Inc. (RLAY)
Binimetinib	ENANTA PHARMACEUTICALS INC (ENTA)
Copanlisib Hydrochloride	Relay Therapeutics, Inc. (RLAY)
Defactinib Hydrochloride	Relay Therapeutics, Inc. (RLAY)
FID-007	Fulgent Genetics Inc. (FLGT)
Ipatasertib	Merus N.V. (MRUS)
Ipatasertib	Relay Therapeutics, Inc. (RLAY)
Larotrectinib Sulfate	Relay Therapeutics, Inc. (RLAY)
Leucovorin	Relay Therapeutics, Inc. (RLAY)
Leucovorin	ADMA BIOLOGICS, INC. (ADMA)
Leucovorin Calcium	Relay Therapeutics, Inc. (RLAY)
Neratinib Maleate	ADMA BIOLOGICS, INC. (ADMA)
Nilotinib Hydrochloride Monohydrate	Relay Therapeutics, Inc. (RLAY)
Niraparib	Black Diamond Therapeutics, Inc. (BDTX)
Olaparib	Relay Therapeutics, Inc. (RLAY)
Olaparib	IGM Biosciences, Inc. (IGMS)
Panitumumab	Relay Therapeutics, Inc. (RLAY)
Panitumumab	ADMA BIOLOGICS, INC. (ADMA)
PI3K-beta Inhibitor GSK2636771	Relay Therapeutics, Inc. (RLAY)
Selumetinib Sulfate	Relay Therapeutics, Inc. (RLAY)
Selumetinib Sulfate	ENANTA PHARMACEUTICALS INC (ENTA)
Sotorasib	ENANTA PHARMACEUTICALS INC (ENTA)
Sotorasib	Relay Therapeutics, Inc. (RLAY)
Sotorasib	ADMA BIOLOGICS, INC. (ADMA)
Sotorasib	Merus N.V. (MRUS)

Phase 1(11)

Drug	Company
aur107	PRF Technologies Ltd. (PRFX)
Avelumab	Accustem Sciences Inc. (ACUT)
BET Bromodomain Inhibitor ZEN-3694	Relay Therapeutics, Inc. (RLAY)
E7389-LF	ENANTA PHARMACEUTICALS INC (ENTA)
Edodekin alfa	ENANTA PHARMACEUTICALS INC (ENTA)
Eribulin	IGM Biosciences, Inc. (IGMS)
Niraparib	PTC THERAPEUTICS, INC. (PTCT)
Pemetrexed	IGM Biosciences, Inc. (IGMS)
Selinexor	IGM Biosciences, Inc. (IGMS)
Topotecan	IGM Biosciences, Inc. (IGMS)
Tuvusertib	Accustem Sciences Inc. (ACUT)

Phase 1/Phase 2(3)

Drug	Company
dazostinag	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
dazostinag	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
platinum	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)

Phase 4(1)

Drug	Company
Leucovorin Calcium	IGM Biosciences, Inc. (IGMS)

BioSniper tracks 53 drugs in development for Solid Neoplasm across 14 companies.

There are 2 clinical trials targeting Solid Neoplasm tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.